← Back to Search

Other

A Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Doses of Prosetin in Healthy Volunteers (PRO-101 Trial)

Phase 1
Waitlist Available
Research Sponsored by ProJenX
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years

Summary

This trial tests a new drug called prosetin on healthy adults to ensure it is safe and understand how the body processes it.

Eligible Conditions
  • Amyotrophic Lateral Sclerosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: ProsetinExperimental Treatment1 Intervention
Part A: single-ascending dose; Part B: multiple doses (7 days)
Group II: PlaceboPlacebo Group1 Intervention
Part A: single-ascending dose; Part B: multiple doses (7 days)

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

ProJenXLead Sponsor
Worldwide Clinical TrialsOTHER
65 Previous Clinical Trials
14,828 Total Patients Enrolled
~9 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top